If you've been grappling with obesity or excess weight and have not achieved success with lifestyle changes alone, Semaglutide may offer the additional support you need
GLP-1 receptor agonists are transforming weight loss medicine, with semaglutide (Ozempic/Wegovy) delivering 12% weight loss and tirzepatide (Mounjaro/Zepbound) achieving 18% in clinical trials
While larger strengths (e.g., 20 mg or 30 mg) are not explicitly listed on LeoLab, alternative UK suppliers such as Peptagenix Peptides offer 10 mg vials , typically priced at 180.00 each , often with volume discount options
Retatrutide is an investigational 39-amino-acid, fatty-acid-acylated triple agonist engineered to engage the GIP, GLP-1, and glucagon receptors from a single peptide backbone
Reyes BAS, Carvalho AF, Szot P, Kalamarides DJ, Wang Q, Kirby LG, et al
[1] The Medicines and Healthcare products Regulatory Agency (MHRA) approved tirzepatide following clinical trials demonstrating improvements in glycaemic control and weight reduction compared to placebo and other diabetes medications
